Mercury Biopharmaceutical Corporation (6932.TWO)

TWD 13.3

(-2.56%)

Total Liabilities Summary of Mercury Biopharmaceutical Corporation

  • Mercury Biopharmaceutical Corporation's latest annual total liabilities in 2023 was 49.72 Million TWD , up 0.24% from previous year.
  • Mercury Biopharmaceutical Corporation's latest quarterly total liabilities in 2024 Q1 was 54.9 Million TWD , up 10.42% from previous quarter.
  • Mercury Biopharmaceutical Corporation reported annual total liabilities of 49.6 Million TWD in 2022, up 1595.73% from previous year.
  • Mercury Biopharmaceutical Corporation reported annual total liabilities of 2.92 Million TWD in 2021, up 855.88% from previous year.
  • Mercury Biopharmaceutical Corporation reported quarterly total liabilities of 54.9 Million TWD for 2024 Q2, down 0.0% from previous quarter.
  • Mercury Biopharmaceutical Corporation reported quarterly total liabilities of 49.72 Million TWD for 2023 Q3, up 6.49% from previous quarter.

Annual Total Liabilities Chart of Mercury Biopharmaceutical Corporation (2023 - 2019)

Historical Annual Total Liabilities of Mercury Biopharmaceutical Corporation (2023 - 2019)

Year Total Liabilities Total Liabilities Growth
2023 49.72 Million TWD 0.24%
2022 49.6 Million TWD 1595.73%
2021 2.92 Million TWD 855.88%
2020 306 Thousand TWD 96.15%
2019 156 Thousand TWD 0.0%

Peer Total Liabilities Comparison of Mercury Biopharmaceutical Corporation

Name Total Liabilities Total Liabilities Difference
Allied Biotech Corporation 910.11 Million TWD 94.537%
GeneFerm Biotechnology Co., Ltd. 282.53 Million TWD 82.402%
Easywell Biomedicals, Inc. 589.98 Million TWD 91.573%
TTY Biopharm Company Limited 3.36 Billion TWD 98.524%
Synmosa Biopharma Corporation 3.62 Billion TWD 98.629%
Orient EuroPharma Co., Ltd. 6.64 Billion TWD 99.252%
Center Laboratories, Inc. 6.78 Billion TWD 99.267%
Tien Liang BioTech Co., Ltd. 161.05 Million TWD 69.127%
Orient Pharma Co., Ltd. 892.18 Million TWD 94.427%
InnoPharmax Inc. 48.64 Million TWD -2.204%
Johnson Chemical Pharmaceutical Works Co., Ltd. 320.99 Million TWD 84.51%
Excelsior Biopharma Inc. 472.87 Million TWD 89.485%
DV Biomed Co., Ltd. 765.87 Million TWD 93.508%
Foresee Pharmaceuticals Co., Ltd. 616.93 Million TWD 91.941%
Handa Pharmaceuticals, Inc. 280.88 Million TWD 82.298%
UniPharma Co., Ltd. 37.4 Million TWD -32.94%
Anxo Pharmaceutical Co., Ltd. 1.01 Billion TWD 95.103%
Alar Pharmaceuticals Inc. 76.08 Million TWD 34.654%
Winston Medical Supply Co., Ltd. 373.87 Million TWD 86.701%
Bioray Biotech Co., Ltd 108.75 Million TWD 54.28%
TSH Biopharm Corporation Limited 133.62 Million TWD 62.791%